Pharma Futur SRL
3.8 FTEPharma Futur reported total assets of 629,295 € at the end of the 2025 financial year (annual accounts filed with the NBB on 23 Jul 2026), with 3.8 full-time equivalents.
By total assets for 2025, Pharma Futur ranks among the 2,000 largest of the 8,148 companies in its sector (NACE 8299) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of Pharma Futur shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Total assets +1653 %
Accounts of the company itself (not consolidated).
The full file covers 4 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Pharma Futur's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 23 Jul 2026
- Year ended 31 Dec 2024filed on 30 Sep 2025
- Year ended 31 Dec 2023filed on 31 Aug 2024
- Year ended 31 Dec 2022filed on 15 Sep 2023
Pharma Futur's financial analysis
- Solvency-38.8%sector median: 47.1%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Pharma Futur
Pharma Futur's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0787.394.827
- VAT number
- BE0787394827
- Peppol
- Registered · 0208:0787394827 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 17 Jun 2022
- Registered office
- 4890 Thimister-Clermont
- Size
- Micro · 3.8 FTE
- Latest accounts
- 2025 · filed on 23 Jul 2026
- Activity
- Other business support service activities n.e.c. (NACE 82990)
Pharma Futur (SRL) has been based in Thimister-Clermont since 2022, active in: other business support service activities n.e.c.. For 2025, it reports a net loss of 269,752 € and equity of −244,402 €; its revenue is not published. With 3.8 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at -38.8%, below the median of its sector (47.1%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Pharma Futur
Companies in the same business, of comparable size and area, outside its group.
- Osman Emir Management Business and other management consultancy activities Sint-Niklaas · balance sheet 87,707 €
- Namik Talia Management Business and other management consultancy activities Sint-Niklaas · balance sheet 182,522 €
- Heyfever Business and other management consultancy activities Antwerp · balance sheet 619,935 €
- Linoar Business and other management consultancy activities Braine-l'Alleud · balance sheet 572,208 €
- QAtive Business and other management consultancy activities Schilde · balance sheet 637,991 €
- Advista Business and other management consultancy activities Ottignies-Louvain-la-Neuve · balance sheet 450,450 €
- Route 2030 Business and other management consultancy activities Antwerp · balance sheet 420,168 €
- Cédric BOGAERTS Other business support service activities n.e.c. Perwez · balance sheet 552,787 €
Frequently asked questions about Pharma Futur
What is the revenue of Pharma Futur?
Pharma Futur files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Pharma Futur?
In Belgium, the VAT number is the company number prefixed with BE: BE0787394827 for Pharma Futur, if the company is VAT-registered. Its company number (CBE) is 0787.394.827.
Where is the registered office of Pharma Futur?
According to the CBE register, the registered office of Pharma Futur is in 4890 Thimister-Clermont.
What is the equity of Pharma Futur?
At the close of the 2025 financial year, the equity of Pharma Futur amounts to -244,402 €, a solvency of -38.8% of total assets.
How many people work at Pharma Futur?
3.8 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Pharma Futur?
The register lists 3 active mandates at Pharma Futur. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is Pharma Futur within its sector?
By total assets for 2025, Pharma Futur ranks among the 2,000 largest of the 8,148 companies in its sector (NACE 8299) in Belgium that filed accounts for that financial year.
The full file of Pharma Futur
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →